However, elevated levels of SPHK1 in PASMC result in an autocrine “inside-out” S1PR-signaling that can stimulate PASMC proliferation via S1PR2, which has been proposed appears upregulated in PASMC of idiopathic PAH patients (9, 15). Here, S1PR2 is linked to pulmonary arterial hypertension.